Hinge Health financials
$97.24+2.13%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $587.9M |
| Gross profit | $468.2M |
| Gross margin | 79.6% |
| Operating income | -$546.4M |
| Net income | -$424.1M |
| Net margin | −72.1% |
| Diluted EPS | $-7.77 |
| EBITDA | -$541.2M |
| Operating cash flow | $171.4M |
| Free cash flow | $165.4M |
| Diluted shares | 54.6M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $208.0M |
| Short-term investments | $155.9M |
| Total debt | $0.00 |
| Total assets | $744.8M |
| Total liabilities | $366.2M |
| Shareholders' equity | $178.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology